TherapeuticsMD, Inc.TXMDNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank93
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P93
Near historical high
vs 3Y Ago
-2.1x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM-34.84%+79.4%
2024-169.39%+72.7%
2023-620.93%-3762.0%
202216.96%+100.6%
2021-2753.25%-1064.3%
2020-236.48%+25.8%
2019-318.70%+59.8%
2018-792.86%-73.4%
2017-457.23%+1.4%
2016-463.63%-